|
|
|
|
Elevated Troponin after Stroke: A Systematic Review
(Click the title below to leave the MDLinx Network and go to the Journal's Website) Cerebrovascular Diseases, 07/02/09 Print Save in My Library Free Abstract Kerr G et al.- Troponin levels are elevated in some acute stroke patients,...
|
|
|
FDA Approves Multaq for Patients with Atrial Fibrillation or Atrial Flutter
Multaq approved to reduce the risk of cardiovascular hospitalization in patients with atrial fibrillation or atrial flutter - U.S commercial launch planned for the summer of 2009 Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today...
|
|
|
The Recent Concept of Heart Function in Elderly Patients
Heart Elderly Patients sponsor Home-General Topics in Email: Password: Remember me Most Viewed Abstracts 1.Your Article Summary (Click the title below to leave the MDLinx Network and go to the Journal's Website) Clinical Medicine:...
|
|
|
FDA Approves Multaq(R) For Patients With Atrial Fibrillation Or Atrial Flutter
Main Category: / CardiologyAlso Included In: Article Date: 03 Jul 2009 Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced that the U.S.Food and Drug Administration (FDA) has approved Multaq(R) (dronedarone) 400 mg Tablets. Patients...
|
|
|
Periodontal Bone Loss Associated With Risk of Stroke in Men
my personal edition> stroke > news E-Mail this DGNews to a colleague DGNews BOSTON -- July 2, 2009 -- Peridontal bone loss is significantly associated with risk of stroke or transient ischaemic attack (TIA) in med aged younger...
|
|
|
Adherence to statin therapy needs improving
MedWire News: Results from a Canadian study indicate that adherence to statins in the general population is low, but that those with the highest levels of adherence have the greatest reduction in cerebrovascular disease incidence.
|
|
|
Cerebrovascular mental stress reactivity is impaired in hypertension
Mental stress causes carotid artery dilation and increases brain blood flow.A series of ultrasound experiments, described in BioMed Central's open access journal Cardiovascular Ultrasound, also found that this dilatory reflex was absent...
|
|
|
FDA Approves Multaq(R) for Patients with Atrial Fibrillation or Atrial Flutter
Multaq(R) approved to reduce the risk of cardiovascular hospitalization in patients with atrial fibrillation or atrial flutter - - U.S.commercial launch planned for the summer of 2009 PARIS, July 2 (HSMN NewsFeed) -- Sanofi-aventis ...
|
|
|
FDA Approves Multaq(R) for Patients with Atrial Fibrillation or Atrial Flutter
PARIS, July 2 /PRNewswire-FirstCall/ -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the U.S.Food and Drug Administration (FDA) has approved Multaq(R) (dronedarone) 400 mg Tablets. Patients with atrial fibrillation ...
|
|
|
FDA Approves Multaq(R) for Patients with Atrial Fibrillation or Atrial Flutter
- Multaq(R) approved to reduce the risk of cardiovascular hospitalization in patients with atrial fibrillation or atrial flutter - PARIS, July 2 /PRNewswire-FirstCall/ -- Sanofi-aventis announced today that the U.S.Food and Drug...
|
|
|
FDA Approves Multaq(R) For Patients With Atrial Fibrillation Or Atrial Flutter
Cardiovascular / Cardiology News Main Category: Cardiovascular / Cardiology Also Included In: Regulatory Affairs / Drug Approvals; Clinical Trials / Drug Trials; Pharma Industry / Biotech Industry email to a friend printer friendly view /...
|
|
|
Sanofi-aventis' Multaq receives US FDA nod to treat patients with atrial fibrillation or atrial flutter
Sanofi-aventis announced that the US Food and Drug Administration (FDA) has approved Multaq (dronedarone) 400 mg tablets.Patients with atrial fibrillation (AF) or atrial flutter (AFL) soon will have a new treatment option to help improve...
|
|
|
FDA Approves Multaq(R) for Patients with Atrial Fibrillation or Atrial Flutter
- Multaq(R) approved to reduce the risk of cardiovascular hospitalization in patients with atrial fibrillation or atrial flutter - PARIS, July 2 /PRNewswire-FirstCall/ -- Sanofi-aventis announced today that the U.S.Food and Drug...
|
|
|
History Of Periodontitis Linked To Cerebrovascular Disease In Men
The potential role of periodontitis, an inflammatory disease of the gums, in the risk of cardiovascular disease, particularly ischemic stroke, has received growing attention during the last decade.A new study is the first prospective...
|
|
|
Link found between history of periodontitis and cerebrovascular disease in men
The potential role of periodontitis, an inflammatory disease of the gums, in the risk of cardiovascular disease, particularly ischemic stroke, has received growing attention during the last decade.A new study is the first prospective...
|
|
|
Association between arterial stiffness and cerebrovascular resistance in the elderly
1Faculty of Applied Health Sciences, RBJ Schlegel-University of Waterloo Research Institute for Aging, University of Waterloo, Waterloo, Ontario, Canada Correspondence: Professor RL Hughson, Faculty of Applied Health Sciences, RBJ Schlegel...
|
|
|
Do statins cut heart attack risk for the healthy?
Researchers say that statins cut the risk of heart attacks by 30% even in healthy people and lower the chance of dying from any cause by 12%, the Daily Mail reported.It said that the drugs are currently only given to people who are at...
|
|
|
FDA Approves Multaq(R) for Patients with Atrial Fibrillation or Atrial Flutter
- Multaq(R) approved to reduce the risk of cardiovascular hospitalization in patients with atrial fibrillation or atrial flutter - PARIS, July 2 /PRNewswire-FirstCall/ -- Sanofi-aventis announced today that the U.S.Food and Drug...
|
|
|
Statins 'lower mortality risk in patients without cardiovascular disease'
A team of international researchers analysed the results of ten large trials, including ALLHAT and ASCOT, of over 70,000 patients to see if statins reduce deaths and major cardiovascular and cerebrovascular events, such as heart...
|
|
|
FDA Approves Multaq for Patients with Atrial Fibrillation or Atrial Flutter
Multaq(R) approved to reduce the risk of cardiovascular hospitalization in patients with atrial fibrillation or atrial flutter - - U.S.commercial launch planned for the summer of 2009 - PARIS, July 2 /PRNewswire-FirstCall/ -- Sanofi...
|
|
|
FDA Approves Multaq(R) for Patients with Atrial Fibrillation or Atrial Flutter
PARIS, July 2 /PRNewswire-FirstCall/ -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the U.S.Food and Drug Administration (FDA) has approved Multaq(R) (dronedarone) 400 mg Tablets. Patients with atrial fibrillation ...
|
|
|
FDA Approves Multaq(R) for Patients with Atrial Fibrillation or Atrial Flutter
- Multaq(R) approved to reduce the risk of cardiovascular hospitalization in patients with atrial fibrillation or atrial flutter - PARIS, July 2 /PRNewswire-FirstCall/ -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the...
|
|
|
FDA Approves Multaq(R) for Patients with Atrial Fibrillation or Atrial Flutter
PARIS, July 2 /PRNewswire-FirstCall/ -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the U.S.Food and Drug Administration (FDA) has approved Multaq(R) (dronedarone) 400 mg Tablets. Patients with atrial fibrillation ...
|
|
|
FDA Approves Multaq(R) for Patients with Atrial Fibrillation or Atrial Flutter
PARIS, July 2 /PRNewswire-FirstCall/ -- Sanofi-aventis (SANthe United States that has shown a clinical benefit to reduce cardiovascular hospitalization in patients with AF/AFL.Multaq(R) is an anti-arrhythmic indicated to reduce the risk...
|
|
|
FDA Approves Multaq(R) for Patients with Atrial Fibrillation or Atrial Flutter
PARIS, July 2 /PRNewswire-FirstCall/ -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the U.S.Food and Drug Administration (FDA) has approved Multaq(R) (dronedarone) 400 mg Tablets. Patients with atrial fibrillation ...
|
